Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula C Eves

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|January 12, 2011
Melanocortin signalling mechanismsPaula C Eves, John W Haycock
Peptides|November 9, 2005
alpha-Melanocyte stimulating hormone, inflammation and human melanomaPaula C Eves, Sheila MacNeil, John W Haycock
International Journal of Radiation Biology|May 31, 2013
Tissue-engineered oral mucosa to study radiotherapy-induced oral mucositisHelen E Colley, Paula C Eves, Abigail Pinnock, et al.
Tissue Engineering. Part C, Methods|October 27, 2010
Establishing a transport protocol for the delivery of melanocytes and keratinocytes for the treatment of vitiligoPaula C Eves, Marta Baran, Nial A Bullett, et al.
The Journal of Investigative Dermatology|August 20, 2003
Tumor necrosis factor alpha increases and alpha-melanocyte-stimulating hormone reduces uveal melanoma invasion through fibronectinIrene Cantón, Paula C Eves, Marika Szabo, et al.
The Journal of Investigative Dermatology|November 26, 2002
Melanoma cell attachment, invasion, and integrin expression is upregulated by tumor necrosis factor alpha and suppressed by alpha melanocyte stimulating hormoneNingwen Zhu, Paula C Eves, Effie Katerinaki, et al.
Tissue Engineering. Part C, Methods|September 28, 2011
A chemically defined carrier for the delivery of human mesenchymal stem/stromal cells to skin woundsNathan G Walker, Anita R Mistry, Louise E Smith, et al.
The Journal of Investigative Dermatology|January 18, 2008
Simplifying the delivery of melanocytes and keratinocytes for the treatment of vitiligo using a chemically defined carrier dressingPaula C Eves, Nial A Bullett, David Haddow, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|January 12, 2011
Melanocortin signalling mechanismsPaula C Eves, John W Haycock
Peptides|November 9, 2005
alpha-Melanocyte stimulating hormone, inflammation and human melanomaPaula C Eves, Sheila MacNeil, John W Haycock
International Journal of Radiation Biology|May 31, 2013
Tissue-engineered oral mucosa to study radiotherapy-induced oral mucositisHelen E Colley, Paula C Eves, Abigail Pinnock, et al.
Tissue Engineering. Part C, Methods|October 27, 2010
Establishing a transport protocol for the delivery of melanocytes and keratinocytes for the treatment of vitiligoPaula C Eves, Marta Baran, Nial A Bullett, et al.
The Journal of Investigative Dermatology|August 20, 2003
Tumor necrosis factor alpha increases and alpha-melanocyte-stimulating hormone reduces uveal melanoma invasion through fibronectinIrene Cantón, Paula C Eves, Marika Szabo, et al.
The Journal of Investigative Dermatology|November 26, 2002
Melanoma cell attachment, invasion, and integrin expression is upregulated by tumor necrosis factor alpha and suppressed by alpha melanocyte stimulating hormoneNingwen Zhu, Paula C Eves, Effie Katerinaki, et al.
Tissue Engineering. Part C, Methods|September 28, 2011
A chemically defined carrier for the delivery of human mesenchymal stem/stromal cells to skin woundsNathan G Walker, Anita R Mistry, Louise E Smith, et al.
The Journal of Investigative Dermatology|January 18, 2008
Simplifying the delivery of melanocytes and keratinocytes for the treatment of vitiligo using a chemically defined carrier dressingPaula C Eves, Nial A Bullett, David Haddow, et al.
Pageof 1